ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,598Medicare Part D Prescriptions Filled, Including Refills
$472K Total Retail Price of All Prescriptions
202 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
FUROSEMIDE 401 400
OMEPRAZOLE 355 335
LEVOTHYROXINE SODIUM 280 257
LISINOPRIL 271 270
METOPROLOL TARTRATE 267 264
SIMVASTATIN 238 221
WARFARIN SODIUM 211 211
NAMENDA 158 158
DONEPEZIL HCL 155 155
CITALOPRAM HBR 155 149
AMLODIPINE BESYLATE 152 152
GABAPENTIN 151 146
RISPERIDONE 139 127
LANTUS 134 134
POLYETHYLENE GLYCOL 3350 129 129
QUETIAPINE FUMARATE 125 96
ESCITALOPRAM OXALATE 119 118
NOVOLOG 119 119
METOPROLOL SUCCINATE 118 116
POTASSIUM CHLORIDE 111 100
ATORVASTATIN CALCIUM 100 100
NYSTOP 97 97
PREDNISONE 96 87
TRIAMCINOLONE ACETONIDE 96 89
ATENOLOL 93 93
ALLOPURINOL 89 89
DIGOXIN 86 85
ADVAIR DISKUS 86 86
CARBIDOPA-LEVODOPA 86 75
MIRTAZAPINE 82 82
TAMSULOSIN HCL 81 81
METFORMIN HCL 80 80
DIVALPROEX SODIUM 71 56
GENERLAC 71 66
NYSTATIN 68 60
SERTRALINE HCL 65 65
VENLAFAXINE HCL ER 63 63
OLANZAPINE 60 59
SPIRIVA 60 60
OXYBUTYNIN CHLORIDE ER 58 58
HYDROCHLOROTHIAZIDE 56 56
TRAZODONE HCL 56 56
RANITIDINE HCL 54 54
AZITHROMYCIN 53 50
CEPHALEXIN 52 52
TRAMADOL HCL 50 48
LEVETIRACETAM 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.